Emergent BioSolutions | Liquidités





Liquidités Changement Date
Acadia Pharmaceuticals USD 847.02M 85.02M 2025-09
Akebia Therapeutics USD 166.44M 29.14M 2025-09
ALKERMES USD 616.45M 95.25M 2025-09
Alnylam Pharmaceuticals USD 1.66B 167M 2025-12
Amarin USD 122.8M 25.08M 2025-09
ANI Pharmaceuticals USD 262.61M 44.81M 2025-09
BioMarin Pharmaceutical USD 1.25B 36.29M 2025-09
Coherus Biosciences USD 103.35M 113.54M 2025-09
Emergent BioSolutions USD 111.7M 23.9M 2023-12
Exact Sciences USD 956M 166.96M 2025-12
Exelixis USD 482.49M 106.19M 2025-12
Glaxosmithkline GBP 3.3B 303M 2025-09
Heron Therapeutics USD 43.07M 26.55M 2025-09
Ionis Pharmaceuticals USD 2.24B 1.94B 2025-09
Ironwood Pharmaceuticals USD 140.41M 47.56M 2025-09
Lexicon Pharmaceuticals USD 21.36M 41.52M 2025-06
Lonza CHF 1.11B 286M 2024-12
Merck USD 18.17B 10.16B 2025-09
Moderna USD 2.6B 1.46B 2025-12
Myriad Genetics USD 145.4M 71M 2025-09
Nektar Therapeutics USD 41.03M 1.96M 2025-09
Neurocrine Biosciences USD 713M 372.8M 2025-12
Pacira USD 147.59M 152.89M 2025-09
Pfizer USD 1.34B 295M 2025-09
PTC Therapeutics USD 672.62M 344.77M 2025-09
Sanofi EUR 7.66B 1.25B 2025-12
Sarepta Therapeutics USD 613.08M 102.48M 2025-09
United Therapeutics USD 1.34B 253M 2025-09
Vanda Pharmaceuticals USD 84.85M 14.83M 2025-12
Xoma USD 143.9M 7.68M 2024-06


Emergent BioSolutions Liquidités - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.